[Disappearance of immunologic abnormalities in rheumatoid nodulosis. Role of pyrithioxin].
Carli
P
P
de Jaureguiberry
J P
JP
Paris
J F
JF
Chagnon
A
A
D005260:Female; D006801:Humans; D008875:Middle Aged; D011746:Pyrithioxin / Q000627:therapeutic use; D012217:Rheumatoid Factor / Q000032:analysis; D012218:Rheumatoid Nodule / Q000188:drug therapy / Q000276:immunology*
D012217:Rheumatoid Factor; D011746:Pyrithioxin
Disparition des anomalies immunologiques au cours d'une nodulite rhumatöide. Rôle de la pyrithioxine.